DAMONA is on a mission to develop small molecule therapeutics to improve the lives of patients suffering from cognitive impairment as a result of depression and other diseases of aging.
Investors 1
| Date | Name | Website |
| 29.09.2022 | Lumira Ven... | lumiravent... |
Mentions in press and media 2
| Date | Title | Description |
| 26.09.2022 | DAMONA Pharmaceuticals Raises US$5.5 Million Seed Stage Financing to Advance Lead Molecule Development to Treat Cognitive Deficits Associated with Depression and Diseases of Aging | TORONTO, Ontario, September 26, 2022 — DAMONA Pharmaceuticals today announced the closing of a seed stage financing round to support the development of its lead therapeutic for the treatment of cognitive symptoms associated with depression ... |
| - | Damona Pharmaceuticals | “Damona Pharmaceuticals TM – Development of novel therapeutic avenues for the treatment of cognitive dysfunctions” |